Search - tctmd.com

Displaying 121 - 140 of 747

Sort: Relevancy | Date

Presentation TCT 2015

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani

October 11, 2015

Presentation TCT 2015

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Presenter: Robert A. Byrne, Stefan K. James

October 11, 2015

Presentation TCT 2015

Update on Neoatherosclerosis: Imaging Recognition, Prevalence, Predictors, and Prognosis

Presenter: Soo-Jin Kang, Gary S. Mintz, Ziad A. Ali

October 11, 2015

Presentation TCT 2015

Does Acute or Late Malapposition Cause Stent Thrombosis?

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Gary S. Mintz, Lisette Okkels Jensen

October 11, 2015

Presentation TCT 2015

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Presenter: Soo-Jin Kang, Gary S. Mintz

October 11, 2015

Presentation TCT 2015

Management Strategies for SFA/Popliteal In-Stent Restenosis

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Restenosis and Stent Thrombosis

Presenter: George D. Dangas, Ehrin J. Armstrong

October 11, 2015

Presentation TCT 2015

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Presenter: Prakash Krishnan, Mahmood K. Razavi, Christopher D. Owens

October 11, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Industry News

Tryton Medical Announces Publication of Post Hoc Analysis of Randomized Clinical Trial in Treatment of Bifurcation Lesions using Tryton Side Branch Stent

September 30, 2015

News Industry News

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

September 23, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Daily News

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

September 15, 2015

News Daily News

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

September 15, 2015

News Daily News

CTO 救助技术后再狭窄率高与血流不理想有关

September 15, 2015

Presentation

Predictors of Restenosis After Contemporary Subintimal Tracking and Reentry Technique (STAR)

Presenter: Mauro Carlino

September 14, 2015

News Industry News

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

September 14, 2015

Advertisement

New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure

Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment

Update on Neoatherosclerosis: Imaging Recognition, Prevalence, Predictors, and Prognosis

Does Acute or Late Malapposition Cause Stent Thrombosis?

Mechanisms and Predictors of Early, Late, and Very Late Stent Thrombosis

Mechanisms and Predictors and Treatment of In-Stent Restenosis

Management Strategies for SFA/Popliteal In-Stent Restenosis

Restenosis and Stent Thrombosis

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Novel Devices Present New Treatment Options for STEMI

Scripps experts present at 2015 TCT scientific symposium

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

Tryton Medical Announces Publication of Post Hoc Analysis of Randomized Clinical Trial in Treatment of Bifurcation Lesions using Tryton Side Branch Stent

Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

High Restenosis Rate After CTO Bailout Technique Linked to Suboptimal Flow

El Alto Índice de Reestenosis Post-Técnica de Rescate de una OTC se asocia a un Flujo Subóptimo

CTO 救助技术后再狭窄率高与血流不理想有关

Predictors of Restenosis After Contemporary Subintimal Tracking and Reentry Technique (STAR)

First Patient Enrolled in CeloNova’s e-COBRA Clinical Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content